Full-Time

Manager – Clinical Study Start Up

Updated on 4/25/2024

Verve Therapeutics

Verve Therapeutics

201-500 employees

Develops gene editing medicines for cardiovascular disease

Biotechnology

Mid, Senior

Cambridge, MA, USA

Required Skills
Communications
Management
Requirements
  • Bachelor's degree in a science-related field; advance degree preferred
  • 5+ years of clinical research / project management experience including clinical site, CRO, and/or sponsor experience
  • Direct experience in preparing and delivering Start-Up activities
  • Familiarity with clinical trial operations, ICH, GCP Guidelines and other applicable regulatory requirements
  • Experience working in a cross-functional team environment
  • Understanding of complexities of study start up
  • Strong interpersonal skill set
  • Highly developed written and verbal communication skills
  • Demonstrated ability to effectively influence and manage within a matrixed organization
  • Demonstrated ability to inspire, motivate, and mentor teams
Responsibilities
  • Lead study start up activities for assigned projects
  • Liaise with internal and external partners to distribute continuous status updates
  • Support the Clinical Operations team in the successful execution of clinical trials
  • Manage IRB/EC and regulatory submission and approvals
  • Collect and QC Regulatory document Green Light Packets for site activation
  • Manage and archive central startup team tools and resources
  • Set up and maintain SSU documents in internal TMF
  • Maintain inspection-ready documentation
  • Assist project teams with trial progress by updating study trackers
  • Organize, attend, and actively contribute to project meetings
  • Identify and implement best practices
  • Liaise with sites, CROs, internal study team, at others
  • Submit clinical documents in quality management system for management and team approval
  • Request, manage, distribute, and track study supplies
  • Perform all activities in compliance with applicable regulations, company policies and guidelines

Verve Therapeutics focuses on the development of single-course gene editing treatments aimed at addressing cardiovascular diseases by lowering LDL cholesterol and triglyceride levels. The company's lead program targets a critical and potentially fatal genetic condition, positioning it at the forefront of genetic medicine in heart disease management. This emphasis on specialized and life-altering therapies makes it an excellent workplace for those passionate about contributing to significant advancements in medical science and patient care.

Company Stage

IPO

Total Funding

$419.3M

Headquarters

Boston, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

3%

1 year growth

10%

2 year growth

92%